NEURAL REGULATION OF PANCREATIC FUNCTION

胰腺功能的神经调节

基本信息

项目摘要

DESCRIPTION (Adapted from Applicant's Abstract): Approximately 10% of patients with acute pancreatitis die from uncontrolled pancreatic inflammation that results in massive fluid losses and shock. The regulation of pancreatic inflammation is poorly understood. In the trachea, sensory nerves regulate inflammation by releasing tachykinins that bind to endothelial cells and induce arteriolar vasodilatation, plasma extravasation and neutrophil infiltration. This well-characterized phenomenon is called neurogenic inflammation. The general hypothesis of this proposal is that neurogenic mechanisms are essential to the pathogenesis of acute pancreatitis. Specifically, we hypothesize that a) tachykinins induce plasma extravasation and neutrophil infiltration in the pancreas by interacting with neurokinin receptors, b) the pro-inflammatory effects of tachykinins are terminated by cell surface peptidases, and c) tachykinins and their receptors regulate inflammation in a widely-used model of acute pancreatitis. Due to the recent availability of "knockout" mice in which the genes encoding neurokinin receptors or cell surface peptidases have been deleted by homologous recombination, these experiments will be performed in mice. Pancreatic inflammation will be assessed by 1) quantifying and localizing plasma extravasation using Evans blue and Monastral blue, respectively, 2) identifying and measuring endothelial cell gaps through which plasma extravasates using a silver stain and light microscopy, 3) quantifying and localizing neutrophil infiltration using myeloperoxidase, and 4) defining the extent of edema, and cytoplasmic vacuolization using histological criteria. Specific Aim 1 will define the contribution of exogenous and endogenous tachykinins to the initiation of acute pancreatic inflammation. The time-course and dose-response will be determined, and the neurokinin receptors that mediate these effects will be identified using antagonists and knockout mice, and localized using receptor-specific antisera. Specific Aim 2 will examine the role of peptidases in the termination of tachykinin-induced pancreatic inflammation. The peptidases neutral endopeptidase and angiotensin converting enzyme will be localized in the pancreas using specific antisera, and their importance in tachykinin-induced inflammation will be determined using inhibitors and knockout mice. Specific Aim 3 will define the importance of sensory nerves, and specifically tachykinins, in the pathogenesis of acute pancreatitis. Using neurokinin receptor antagonists, peptidase inhibitors, and knockout mice, we will delineate the neurogenic mechanisms that regulate inflammation in acute pancreatitis.
描述(改编自申请人摘要):约10% 急性胰腺炎患者死于不受控制的胰腺炎 导致大量体液流失和休克的炎症。 调控 胰腺炎的发病机制知之甚少 在气管中,感觉 神经通过释放速激肽来调节炎症, 内皮细胞和诱导小动脉血管扩张,血浆外渗 和中性粒细胞浸润。 这种特征鲜明的现象被称为 神经源性炎症 这一建议的一般假设是, 神经原性机制在急性脑梗死的发病机制中至关重要, 胰腺炎 具体来说,我们假设a)速激肽诱导 胰腺中的血浆外渗和中性粒细胞浸润, 与神经激肽受体相互作用,B) 速激肽由细胞表面肽酶终止,和c)速激肽 它们的受体在广泛使用的急性炎症模型中调节炎症 胰腺炎 由于最近出现了“敲除”小鼠,其中 编码神经激肽受体或细胞表面肽酶的基因已经被 通过同源重组删除,这些实验将在 小鼠 胰腺炎症将通过1)定量和 使用伊文思蓝和单星蓝定位血浆外渗, 2)识别和测量内皮细胞间隙, 使用银染色和光学显微镜检查血浆外渗,3) 使用髓过氧化物酶定量和定位嗜中性粒细胞浸润, 以及4)使用细胞内空泡形成来确定水肿和细胞质空泡形成的程度。 组织学标准。 具体目标1将确定以下方面的贡献: 外源性和内源性速激肽对急性胰腺炎的启动作用 炎症 将确定时间过程和剂量反应, 神经激肽受体介导这些影响将确定使用 拮抗剂和敲除小鼠,并使用受体特异性 抗血清 具体目标2将研究肽酶在 终止速激肽诱导的胰腺炎症。 肽酶 中性内肽酶和血管紧张素转换酶将定位于 使用特异性抗血清的胰腺,以及它们在 将使用抑制剂测定速激肽诱导的炎症, 敲除小鼠 具体目标3将定义感觉神经的重要性, 特别是速激肽在急性胰腺炎发病机制中的作用。 使用神经激肽受体拮抗剂、肽酶抑制剂和基因敲除 小鼠,我们将描绘调节炎症的神经机制 急性胰腺炎

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kimberly Saunders Kirkwood其他文献

Neoadjuvant Therapy Decreases Postoperative Pancreatic Fistula, Delayed Gastric Emptying, and Systemic Morbidity in Patients Undergoing Pancreaticoduodenectomy: An American College of Surgeons NSQIP Analysis
  • DOI:
    10.1016/j.jamcollsurg.2020.07.529
  • 发表时间:
    2020-10-01
  • 期刊:
  • 影响因子:
  • 作者:
    Alexa Glencer;Jeremy Sharib;Paige Bracci;Tyler J. York;Sophia Hernandez;Kimberly Saunders Kirkwood;Carlos Uriel Corvera
  • 通讯作者:
    Carlos Uriel Corvera
Minimally Invasive Splenectomy Is Associated with Decreased Serious Complications: A 2008-2018 NSQIP Analysis
  • DOI:
    10.1016/j.jamcollsurg.2020.07.195
  • 发表时间:
    2020-10-01
  • 期刊:
  • 影响因子:
  • 作者:
    Sophia Hernandez;Tyler J. York;Alexa Glencer;Jeremy Sharib;James Ross;Alexander Sehyun Kim;Paige Bracci;Kimberly Saunders Kirkwood
  • 通讯作者:
    Kimberly Saunders Kirkwood

Kimberly Saunders Kirkwood的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kimberly Saunders Kirkwood', 18)}}的其他基金

Advancing the Clinical Translation of Cyst Fluid Assays for Early Detection of Pancreatic Cancer
推进囊肿液检测的临床转化以早期检测胰腺癌
  • 批准号:
    10639705
  • 财政年份:
    2023
  • 资助金额:
    $ 13.71万
  • 项目类别:
Neural Regulation of Pancreatic Function
胰腺功能的神经调节
  • 批准号:
    8277330
  • 财政年份:
    1995
  • 资助金额:
    $ 13.71万
  • 项目类别:
NEURAL REGULATION OF PANCREATIC FUNCTION
胰腺功能的神经调节
  • 批准号:
    6176209
  • 财政年份:
    1994
  • 资助金额:
    $ 13.71万
  • 项目类别:
NEURAL REGULATION OF PANCREATIC FUNCTION
胰腺功能的神经调节
  • 批准号:
    2905536
  • 财政年份:
    1994
  • 资助金额:
    $ 13.71万
  • 项目类别:
NEURAL REGULATION OF PANCREATIC FUNCTION
胰腺功能的神经调节
  • 批准号:
    6524108
  • 财政年份:
    1994
  • 资助金额:
    $ 13.71万
  • 项目类别:
NEURAL REGULATION OF PANCREATIC FUNCTION
胰腺功能的神经调节
  • 批准号:
    2706261
  • 财政年份:
    1994
  • 资助金额:
    $ 13.71万
  • 项目类别:

相似海外基金

Evaluation of Transmission Low-frequency Raman Spectroscopy for Application to Quality Assurance of Continuous Manufactured Solid Dosage Forms
透射低频拉曼光谱在连续生产固体剂型质量保证中的应用评价
  • 批准号:
    23K06071
  • 财政年份:
    2023
  • 资助金额:
    $ 13.71万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
CAREER: microRNA-mediated regulation of dosage sensitive genes involved in morphogenesis
职业:微小RNA介导的形态发生剂量敏感基因的调节
  • 批准号:
    2238425
  • 财政年份:
    2023
  • 资助金额:
    $ 13.71万
  • 项目类别:
    Continuing Grant
Use of Additives in Oral Solid Dosage Forms to Inhibit Nitrosamine Formation
在口服固体剂型中使用添加剂抑制亚硝胺形成
  • 批准号:
    2896874
  • 财政年份:
    2023
  • 资助金额:
    $ 13.71万
  • 项目类别:
    Studentship
A Phase 2, randomized, double-blind, 4-arm, multicenter study to demonstrate the efficacy and safety of topical dosage formulations of a prescription drug product for actinic keratosis
一项 2 期、随机、双盲、4 组、多中心研究,旨在证明处方药局部剂量制剂治疗光化性角化病的有效性和安全性
  • 批准号:
    10820810
  • 财政年份:
    2023
  • 资助金额:
    $ 13.71万
  • 项目类别:
Estimation of optimal dosage of opioid based on vascular stiffness value
基于血管硬度值估算阿片类药物最佳剂量
  • 批准号:
    23K15598
  • 财政年份:
    2023
  • 资助金额:
    $ 13.71万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Mapping and prediction of quantitative transcription factor dosage effects to understand variation in craniofacial morphology and disease
定量转录因子剂量效应的绘图和预测,以了解颅面形态和疾病的变化
  • 批准号:
    10641572
  • 财政年份:
    2023
  • 资助金额:
    $ 13.71万
  • 项目类别:
Creation of trait diversity through gene dosage effects in allopolyploid wheat
通过异源多倍体小麦基因剂量效应创造性状多样性
  • 批准号:
    22KJ1943
  • 财政年份:
    2023
  • 资助金额:
    $ 13.71万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Optimizing dosage and CTA-Enabling Pre-clinical Gene Therapy Studies for Creatine Transporter Deficiency
优化剂量和支持 CTA 的肌酸转运蛋白缺乏症临床前基因治疗研究
  • 批准号:
    491901
  • 财政年份:
    2023
  • 资助金额:
    $ 13.71万
  • 项目类别:
    Operating Grants
SOCIETAL IS A SMALL BUSINESS CONCERN FOR DOSAGE FORM DEVELOPMENT, MANUFACTURE, AND STABILITY STUDIES OF NCGC72
社会是小企业关注 NCGC72 的剂型开发、生产和稳定性研究
  • 批准号:
    10953952
  • 财政年份:
    2023
  • 资助金额:
    $ 13.71万
  • 项目类别:
Modulating Exercise Dosage to Improve Concussion Rehabilitation: A Randomized Clinical Trial
调节运动量以改善脑震荡康复:一项随机临床试验
  • 批准号:
    10412780
  • 财政年份:
    2022
  • 资助金额:
    $ 13.71万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了